Hyphens Pharma International Limited (SGX:1J5)
Singapore
· Delayed Price · Currency is SGD 0.315
-0.005 (-1.56%)
At close: Mar 9, 2026
SGXC:1J5 Ratios and Metrics
Market cap in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 97 | 103 | 88 | 88 | 103 | 93 | Upgrade
|
| Market Cap Growth | 10.52% | 17.54% | -0.10% | -14.81% | 11.67% | -2.12% | Upgrade
|
| Enterprise Value | 82 | 99 | 81 | 61 | 82 | 66 | Upgrade
|
| Last Close Price | 0.32 | 0.34 | 0.27 | 0.26 | 0.26 | 0.23 | Upgrade
|
| PE Ratio | 16.94 | 17.71 | 8.64 | 10.29 | 9.11 | 13.53 | Upgrade
|
| Forward PE | 7.88 | 8.77 | 7.75 | 8.88 | 9.49 | 12.88 | Upgrade
|
| PS Ratio | 0.55 | 0.58 | 0.45 | 0.52 | 0.64 | 0.74 | Upgrade
|
| PB Ratio | 1.34 | 1.43 | 1.18 | 1.34 | 1.47 | 1.69 | Upgrade
|
| P/TBV Ratio | 2.11 | 2.25 | 1.90 | 2.24 | 2.07 | 2.54 | Upgrade
|
| P/FCF Ratio | 5.41 | 5.75 | - | 16.50 | 6.34 | 17.36 | Upgrade
|
| P/OCF Ratio | 5.19 | 5.52 | 1467.17 | 15.61 | 6.13 | 15.34 | Upgrade
|
| PEG Ratio | 0.80 | 0.90 | 0.45 | 88.79 | 0.53 | 1.62 | Upgrade
|
| EV/Sales Ratio | 0.46 | 0.56 | 0.42 | 0.36 | 0.50 | 0.52 | Upgrade
|
| EV/EBITDA Ratio | 4.83 | 5.80 | 5.45 | 4.83 | 5.08 | 7.24 | Upgrade
|
| EV/EBIT Ratio | 5.78 | 6.94 | 6.08 | 5.54 | 5.65 | 8.45 | Upgrade
|
| EV/FCF Ratio | 4.58 | 5.50 | - | 11.43 | 5.00 | 12.34 | Upgrade
|
| Debt / Equity Ratio | 0.13 | 0.13 | 0.19 | 0.10 | 0.08 | 0.15 | Upgrade
|
| Debt / EBITDA Ratio | 0.55 | 0.55 | 0.86 | 0.49 | 0.33 | 0.82 | Upgrade
|
| Debt / FCF Ratio | 0.52 | 0.52 | - | 1.28 | 0.35 | 1.53 | Upgrade
|
| Net Debt / Equity Ratio | -0.24 | -0.24 | -0.12 | -0.25 | -0.44 | -0.21 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.02 | -1.02 | -0.62 | -1.31 | -1.92 | -1.24 | Upgrade
|
| Net Debt / FCF Ratio | -0.97 | -0.97 | 8.29 | -3.10 | -1.89 | -2.12 | Upgrade
|
| Asset Turnover | 1.37 | 1.37 | 1.52 | 1.45 | 1.52 | 1.39 | Upgrade
|
| Inventory Turnover | 3.35 | 3.35 | 4.24 | 4.68 | 4.30 | 3.72 | Upgrade
|
| Quick Ratio | 1.23 | 1.23 | 1.18 | 1.30 | 1.67 | 1.12 | Upgrade
|
| Current Ratio | 1.92 | 1.92 | 1.84 | 1.87 | 2.24 | 1.74 | Upgrade
|
| Return on Equity (ROE) | 8.32% | 8.32% | 15.47% | 12.61% | 18.25% | 13.44% | Upgrade
|
| Return on Assets (ROA) | 6.87% | 6.87% | 6.50% | 5.85% | 8.45% | 5.39% | Upgrade
|
| Return on Invested Capital (ROIC) | 19.60% | 17.97% | 19.52% | 20.15% | 27.82% | 18.98% | Upgrade
|
| Return on Capital Employed (ROCE) | 19.30% | 19.30% | 17.10% | 15.40% | 19.40% | 13.80% | Upgrade
|
| Earnings Yield | 6.01% | 5.65% | 11.58% | 9.72% | 10.97% | 7.39% | Upgrade
|
| FCF Yield | 18.49% | 17.39% | -1.28% | 6.06% | 15.78% | 5.76% | Upgrade
|
| Dividend Yield | 4.69% | 4.48% | 5.55% | 3.28% | 4.22% | 2.91% | Upgrade
|
| Payout Ratio | 93.77% | 93.77% | 26.05% | 169.97% | 18.23% | 27.21% | Upgrade
|
| Buyback Yield / Dilution | 0.20% | 0.20% | -1.74% | 0.27% | -2.66% | -0.60% | Upgrade
|
| Total Shareholder Return | 4.88% | 4.67% | 3.81% | 3.55% | 1.57% | 2.31% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.